Orano USA

Headquartered in Bethesda, Maryland, near the nation's capital, Orano USA is a leading technology and services provider for decommissioning shutdown nuclear energy facilities, managing used nuclear fuel, conducting federal site clean-up and closure, and the sale of uranium, conversion, and enrichment services to the U.S. commercial and federal markets.

In the nuclear medicine field, Orano Med is developing a new generation of targeted therapies against cancer using the unique properties of lead-212 (212Pb), a rare alpha-emitting radioisotope and one of the more potent therapeutic payloads against cancer cells.

Follow us
By clicking “I accept Cookies”, you agree with the cookies use to enhance site navigation, analyze site usage and compile statistics. To get more information, please read our Cookies Policy in the Legal Notice